deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01807091

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Feasibility of Outpatient Induction Chemotherapy for Adult Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Sponsor: National Cancer Institute (NCI)

Conditions Adult Acute Myeloid Leukemia Adult Myelodysplastic Syndrome
Interventions Chemotherapy
Updated 15 times since 2017 Last updated: Feb 11, 2021 Started: May 21, 2013 Primary completion: Jan 8, 2020 Completion: Jan 8, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01807091, this NA trial focuses on Adult Acute Myeloid Leukemia and Adult Myelodysplastic Syndrome and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 15 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Nov 2019 · 11 months · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~Oct 2020 · 8 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Dec 2021 — Dec 2022 [monthly]

    Completed NA

▶ Show 10 earlier versions

  1. Apr 2021 — Dec 2021 [monthly]

    Completed NA

  2. Jan 2021 — Apr 2021 [monthly]

    Completed NA

  3. Oct 2020 — Jan 2021 [monthly]

    Completed NA

  4. Feb 2020 — Oct 2020 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  5. Nov 2019 — Feb 2020 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  6. Dec 2018 — Nov 2019 [monthly]

    Recruiting NA

  7. Jun 2018 — Dec 2018 [monthly]

    Recruiting NA

  8. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

  9. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  10. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Washington
Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations